Press Release Summary:
The Integra® Titan™ Reverse Shoulder System-S (RSS-S) is offered with advanced imaging analysis that improves fit and stability of patients with varying anatomy. The RSS-S comes with independent central screw for immediate fixation of the patient’s bone and porous-coated central post that enables the bone to grow onto the implant.
Original Press Release:
Integra LifeSciences Launches Integra® Titan™ Reverse Shoulder System-S
PLAINSBORO, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced the full market release of the Integra® Titan™ Reverse Shoulder System-S (RSS-S). This launch includes a new glenoid baseplate design to expand the Integra® Titan™ Reverse Shoulder System.
The new glenoid baseplate was designed with advanced imaging analysis to improve fit and stability for patients of varying anatomy. In reverse shoulder arthroplasty, strong fixation in the patient’s bone is key for long-term success of the implant construct. The new RSS-S baseplate was designed to achieve immediate fixation with an independent central screw, and the porous-coated central post allows the patient’s bone to grow onto the implant to further maximize the potential for long-term fixation.
“We designed the Titan Reverse Shoulder System-S to leverage the latest data on glenoid morphology in various patient populations, while streamlining the instrumentation to improve the flow of each case,” said Dr. Matthew Ramsey of the Rothman Institute and a design surgeon of the system. “The new system builds upon the established legacy of our diaphyseal-fit humeral stems, which allow me to treat my patients without cement in primary and revision surgeries.”
“The Titan Reverse Shoulder System is the foundation of our shoulder portfolio and a key growth driver in our Extremity Orthopedics franchise,” said Robert T. Davis, Jr., corporate vice president and president, Orthopedics and Tissue Technologies. “The launch of RSS-S demonstrates our commitment to continuous innovation in the shoulder arthroplasty space with the goal of improving patient outcomes.”
The Titan Reverse Shoulder System-S was developed with the following industry thought leaders: Matthew Ramsey, MD; William Geissler, MD; Reza Omid, MD; Jean-Marc Glasson, MD; Phillip Duke, MB.BS, FRACS, FA(ORTH)A; and Mark Ross, MB.BS.FRACS, FA(ORTH)A.
Integra LifeSciences is a global leader in regenerative technologies, neurosurgical and extremity orthopedic solutions dedicated to limiting uncertainty for clinicians, so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, Cadence®, Certas™, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®, Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®, SurgiMend®, TCC-EZ®, Titan™ and VersaTru™. For the latest news and information about Integra and its brands, please visit www.integralife.com.
CONTACT: Integra LifeSciences Holdings Corporation